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Regulation  of  an  immune  response  requires  complex  crosstalk  between  cells  of the  innate  and  adaptive
immune  systems,  via  both  cell–cell  contact  and  secretion  of  cytokines.  An important  cytokine  with a
broad  regulatory  role  in the immune  system  is  transforming  growth  factor-  (TGF-).  TGF-  is  produced
by  and  has  effects  on  many  different  cells  of  the  immune  system,  and  plays  fundamental  roles  in thedaptive immunity
endritic cell
ntegrin
-cell
GF
regulation  of immune  responses  during  homeostasis,  infection  and  disease.  Although  many  cells  can
produce  TGF,  it is always  produced  as an  inactive  complex  that  must  be activated  to  bind  to  the TGF
receptor  complex  and  promote  downstream  signalling.  Thus,  regulation  of TGF  activation  is  a  crucial
step  in  controlling  TGF  function.  This  review  will  discuss  how  TGF  controls  diverse  immune  responses
and  how  TGF  function  is regulated,  with  a focus  on  recent  work  highlighting  a critical  role  for  the integrin
v8  expressed  by dendritic  cells  in  activating  TGF.GF structure and signalling
TGF is the prototypical member of the TGF family of
ytokines, which consists of 33 members and includes the activins,
nhibins, bone morphogenetic proteins (BMPs) and growth and dif-
erentiation factors (GDFs) (Derynck and Miyazono 2008). There are
hree isoforms of TGF (TGF1, 2 and 3), all of which have overlap-
ing but non-redundant functions (Annes et al. 2003). Importantly,
ll three TGF isoforms are produced as inactive complexes, which
ust be activated to bind to their receptors. Thus, TGF genes
ncode a single product consisting of an N-terminal propeptide
alled latency associated peptide (LAP) and a C-terminal active
ytokine moiety (herein referred to as active TGF). After trans-
ation, the LAP-active TGF product dimerises via disulphide bond
ormation. LAP and active TGF are then cleaved from each other
Abbreviations: TGF, transforming growth factor ; BMP, bone morphogenetic
rotein; GDF, growth and differentiation factor; TGFR, TGF receptor; LAP, latency-
ssociated peptide; Treg, regulatory T-cell; nTreg, natural regulatory T-cell; iTreg,
nduced regulatory T-cell; EAE, experimental autoimmune encephalitis; DC, den-
ritic cell; LC, Langerhans cells; AHR, airway hyper-responsiveness.
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in the Golgi by the enzyme furin, but remain non-covalently asso-
ciated in a conformation that blocks active TGF binding to its
receptor (Fig. 1) (Annes et al. 2003). Recent structural data show
that LAP forms the arms of a ‘straightjacket’ that wrap around active
TGF to mask the receptor binding sites and keep the complex in
an inactive form (Shi et al. 2011). Thus, TGF can only signal via
the TGF receptor and trigger biological effects once the complex
is activated.
The TGF receptor complex consists of two  receptor subunits,
TGF receptor (TGFR) I and II. Initial engagement of active TGF
with TGFRII causes a conformational change in the receptor which
facilitates dimerisation with TGF RI (Fig. 1). A dimer of TGFRII
and TGFRI forms a tetrameric complex bound to the active TGF
dimer, to initiate downstream signalling pathways (Kang et al.
2009).
Classically, TGF receptor signalling occurs by activating the
Smad-dependent intracellular signalling pathway. Both TGFRI
and II are serine-threonine kinases, and upon formation of the
active TGF–TGFR complex, the cytoplasmic domain of TGFRII
phosphorylates the cytoplasmic domain of TGFRI, which recruits
either Smad2 or Smad3 to TGFRI. Smad2/3 is then phosphory-
lated by TGFRI, and a homodimer binds to Smad4 before shuttling
to the nucleus where it acts as a transcription factor to regulate
Open access under CC BY license. gene transcription (Fig. 1) (Shi and Massagué 2003). The inter-
action of Smad4 with Smad2/3 can be blocked by the inhibitory
Smad, Smad7, which can act as an important negative regulator of
TGF signalling (Monteleone et al. 2008). However, TGF can also
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Fig. 1. Activated TGF signals via Smad-dependent and independent pathways. Once the latent complex of TGF is activated, active TGF binds to TGFRII, resulting in
recruitment of a TGFRI. Phosphorylation of TGFRI by TGFRII allows either SMAD2 or SMAD3 to bind. TGFRI phosphorylates SMAD2/3, which dissociates from the
receptor complex and binds SMAD4. SMAD7 is able to disrupt SMAD2/3 attachment to the receptor complex. SMAD4 in complex with SMAD2/3 translocates to the nucleus
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egulation of TGF signalling. The complex is able to recruit coactivators or corepre
he  cell type. TGF can also signal through poorly understood SMAD-independent p
ropagate signals via a number of Smad-independent routes
ncluding the MAP  kinase, PI3-Kinase and Wnt  pathways (Guo and
ang 2009). Thus, as TGF can regulate numerous intracellular sig-
alling pathways and many cells express TGFRs, this pleiotropic
ytokine needs to be carefully regulated. As will be discussed, a key
egulatory step in the TGF signalling pathway is at the level of
ytokine activation.
egulation of immunity by TGF
Although TGF can have diverse effects on multiple cell types,
he cytokine plays a non-redundant, crucial role in regulating
mmunity. TGF is produced by, and has diverse functional effects
n, many cells of the immune system. The most highly expressed
soform of TGF in the immune system is TGF1, and mice lack-
ng this isoform die early in life from multi-organ inﬂammation
Shull et al. 1992; Kulkarni et al. 1993). Thus, TGF has classically
een proposed to have important anti-inﬂammatory effects in the
mmune system. However, it is clear that TGF can have both pro-
nd anti-inﬂammatory effects depending on the context in which
t is acting. Although it should be noted that virtually all cells of the
mmune system can produce and respond to TGF to some extent
see Li et al. 2006a for detailed review), below we highlight the
mportant roles of TGF in regulating T-cells and dendritic cells,
he key players in driving the adaptive immune response.
GF regulation of T-cells
D4+ T-cells
A major focus has been placed on the role of TGF in regula-
ion of CD4+ T-cell responses. Multi-organ inﬂammation observed
n TGF1−/− mice is completely rescued if mice are crossed to a
HCII knockout background, highlighting a crucial role for TGF
n regulating pathological CD4+ T-cell responses (Letterio et al.
996). Additionally, early in vitro evidence suggested that TGFphosphorylation of SMADs results in their export from the nucleus, ensuring tight
 to either up- or down-regulate expression of a wide range of genes, dependent on
ays including MAP kinase, PI3 kinase, Wnt  and other pathways.
can directly downregulate both Th1 and Th2 cell differentiation
by suppressing T-bet and GATA-3 expression respectively (Li et al.
2006a). More recently, generation of mice lacking TGFRII speciﬁ-
cally on T-cells has re-inforced the importance of TGF in regulating
T-cell responses in vivo, as mice develop multi-organ inﬂamma-
tion similar to that seen in TGF1−/− mice (Li et al. 2006b; Marie
et al. 2006). Disease development correlated with an enhanced Th1
response; however, in the absence of the Th1 master transcription
factor T-bet, mice lacking TGFRII on T-cells developed multi-organ
inﬂammation associated with an enhanced Th2 response (Li et al.
2006b). Together, the data support a key role for TGF in attenuat-
ing both Th1 and Th2 CD4+ T-cell activation to maintain immune
homeostasis.
In addition to the direct effects on effector Th1 and Th2
responses, TGF can promote immunosuppression via direct induc-
tion of regulatory T-cells (Tregs), a key CD4+ T-cell subset involved
in the suppression of self-harmful immune responses. Tregs are
either produced in the thymus during T-cell development (natu-
ral or nTregs) or induced from naive CD4+ T-cells in the periphery
(so-called induced or iTregs) and are marked by expression of the
transcription factor Foxp3 (Sakaguchi and Powrie 2007). Although
earlier evidence suggested that TGF played no role in the devel-
opment of nTreg in the thymus (Marie et al. 2005, 2006; Li et al.
2006b), it now appears that TGF is involved in the early differ-
entiation of T-cells to nTregs in the thymus. Thus, neonatal mice
lacking TGFRI on T-cells show reduced levels of thymic Foxp3+
Tregs, but these are expanded by enhanced IL-2 production in the
ﬁrst week of life (Liu et al. 2008).
However, it is clear that TGF plays a fundamental role in the
induction of iTregs in the periphery. In combination with IL-2
in vitro, TGF directly promotes expression of Foxp3 in CD4+ T-
cells, converting them to a regulatory phenotype (Chen et al. 2003).
Both TGF1−/− mice and mice lacking TGFRII on T-cells show
reduced Foxp3+ Treg numbers in the periphery (Marie et al. 2005,
2006; Li et al. 2006b), suggesting a key role for TGF in induc-
tion/maintenance of Tregs in vivo. Induction of iTregs is particularly
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revalent in the intestine, where they are required to prevent reac-
ions against commensal bacteria and innocuous food antigens. In
ddition to induction and maintenance of Foxp3 expression, TGF
as also been shown to be important in the functional ability of
regs to suppress immune responses (Marie et al. 2005; Fahlén et al.
005).
In contrast to the negative regulatory role in CD4+ T-cell
esponses, TGF has been shown to be a key cytokine in the dif-
erentiation of pro-inﬂammatory Th17 cells in mice and humans
Littman and Rudensky 2010). In combination with the inﬂam-
atory cytokines IL-6, IL-1 IL-21 and/or IL-23, TGF promotes
xpression of the master transcription factor of Th17 cells, RORt
Korn et al. 2007). Although recent work has suggested that Th17
ells can differentiate into potent effector cells in the absence of
GF (Ghoreschi et al. 2010), many studies have demonstrated
n important role for TGF in development of Th17 cells in vivo.
or example, blockade of TGF signalling in T-cells (via expression
f a dominant-negative TGFRII) or local administration of anti-
GF blocking antibodies prevents the development of Th17 cells
nd protects mice from disease during experimental autoimmune
ncephalitis (EAE) (Veldhoen et al. 2006). Similarly, mice lacking
GF production in T-cells show reduced differentiation of Th17
ells and protection from EAE (Li et al. 2007). Indeed, it appears
hat Th17 cells themselves are an important source of TGF that
cts in an autocrine manner to maintain Th17 cells in vivo (Gutcher
t al. 2011).
In addition to promoting Th17 cell responses recent data suggest
hat, in combination with IL-4, TGF can drive differentiation of a
ovel CD4+ effector T-cell subset called Th9 cells, which are char-
cterised by expression of IL-9 (Dardalhon et al. 2008; Veldhoen
t al. 2008). In the presence of IL-4, TGF induces expression of
he transcription factor PU.1, which can directly drive expression
f IL-9 (Chang et al. 2010). Th9 cells have effector properties and are
nvolved in responses to helminth infection and induction of tissue
nﬂammation (Dardalhon et al. 2008; Veldhoen et al. 2008). Thus,
t is clear that TGF can both inhibit and promote differentiation of
ffector CD4+ Th cell subsets.
Interestingly, the levels of active TGF present during an
mmune response may  be important in determining whether TGF
romotes or inhibits T-cell responses. At low concentrations, TGF
ynergises with pro-inﬂammatory cytokines to promote Th17 dif-
erentiation by inducing RORt expression (Zhou et al. 2008).
owever, at higher concentrations TGF promotes Foxp3 induction
nd iTreg formation (Zhou et al. 2008). Thus, although the signif-
cance in vivo remains to be determined, these data suggest that
lterations in local active TGF concentrations may  have profound
ffects on whether CD4+ T-cells are pushed towards a suppressive
r effector phenotype.
ther T-cell subsets
In addition to regulating CD4+ T-cell subsets, TGF plays impor-
ant roles in controlling other T-cell compartments. Thus, TGF
ignalling is involved in CD8+ T-cell development in the thymus,
nd restrains CD8+ T-cell activation in the periphery of mice (Li
t al. 2006b; Marie et al. 2006). Also, TGF limits the expansion of
D8+ T-cells during Listeria monocytogenes infection by inducing
poptosis during clonal expansion (Sanjabi et al. 2009). TGF sig-
alling is also important for NKT cell homeostasis and is required
or the thymic development of canonical CD1d-restricted NKT cells,
ometimes referred to as invariant NKT (iNKT) cells (Li et al. 2006b;
arie et al. 2006; Doisne et al. 2009; Havenar-Daughton et al.
012). Conversely, TGF signalling is required for the suppression
f pathogenic effector function in an NK1.1+ T-cell subset (Marie
t al. 2006). Finally, TGF has recently been shown to be criti-
al in the formation of CD8+ intraepithelial lymphocytes in thelogy 217 (2012) 1259– 1265 1261
intestine, which are proposed to be important in regulation of
mucosal immune responses (Konkel et al. 2011).
Taken together, it is clear that TGF plays essential roles in
the regulation of T-cell development and function, acting to tune
immune responses by promoting or suppressing different subsets
during homeostasis and infection.
TGF regulation of dendritic cells
The action of TGFon dendritic cells (DCs) can both promote and
inhibit DC-mediated immune responses. TGF can downregulate
the antigen-presenting function and expression of co-stimulatory
molecules by DCs in vitro (Strobl and Knapp 1999). Mice express-
ing a dominant negative version of TGFRII under the control of
the CD11c promoter do not show any differences in DCs during
homeostasis (Laouar et al. 2005) but are more prone to the develop-
ment of EAE due to enhanced Th1 and Th17 responses (Laouar et al.
2008). Thus, TGF appears to be important in regulating the ability
of DCs to control self-reactive T-cells during models of autoim-
munity. However, the exact mechanisms by which TGF regulate
DC-mediated responses in vivo require further exploration.
Although TGF does not appear to be important in the devel-
opment and homeostasis of conventional DCs, TGF plays an
important role in the homeostasis of Langerhans cells (LCs), a
unique subset of DCs found in the epidermis of the skin (Kaplan
2010). TGF1−/− mice completely lack LCs (Borkowski et al.
1996), suggesting an important role for TGF in the develop-
ment/maintenance of LCs in the skin. Indeed, subsequent work
has shown that TGF1 production by LCs acting in an autocrine
manner is important for LC homeostasis, as expression of a domi-
nant negative TGFRII in LCs (Kaplan et al. 2007) or deletion of the
TGFRI speciﬁcally in LCs (Zahner et al. 2011) results in very low LC
numbers in mice. Ablation of TGF signalling in total skin DCs (by
crossing mice expressing a conditional allele of the TGFRI recep-
tor to mice expressing CD11c-Cre) conﬁrmed that TGF is required
to maintain LCs in skin (Kel et al. 2010). The authors showed that
TGFRI deletion in skin DCs was incomplete in neonatal mice, but
increased in the ﬁrst week of life and correlated with a reduction in
LC numbers (Kel et al. 2010). Lack of TGF signalling in skin DCs also
enhanced LC migration and maturation in steady state (Kel et al.
2010). Together, the data suggest that TGF production and sig-
nalling are crucial for the development, maintenance and function
of LCs in vivo.
TGF production in the immune system
Many different immune cell types are capable of producing
TGF (Li et al. 2006a).  Studies to investigate the important cellular
sources of TGF in vivo have highlighted an important role for T-
cell produced TGF. Thus, conditional deletion of TGF1 expression
in CD4+ and CD8+ T-cells (by crossing mice carrying a conditional
ﬂoxed allele of TGF1 with mice expressing CD4-Cre) resulted in
age-related autoimmune disease, characterised by T-cell activa-
tion and colitis (Li et al. 2007). This phenotype is similar to that
seen in mice expressing a dominant negative TGFRII in T-cells
(Gorelik and Flavell 2000) suggesting that TGF acts upon T-cells
in an autocrine fashion. However, as the autoimmune phenotype
observed is not as severe as that in either TGF1−/− mice or mice
completely lacking TGFRII expression in T-cells, this suggests that
there are other important cellular sources of TGF that act to
control T-cells. Indeed, to date, TGF knockout in any one single
cell type has not recapitulated the severe phenotype observed in
TGF1−/− mice and mice lacking TGFRII in T-cells, strongly sug-
gesting that there are multiple important cellular sources of TGF
production in vivo. The autocrine function of TGF1 in both T cells
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Li et al. 2007; Gutcher et al. 2011) and LC (Kaplan et al. 2007) sug-
ests that TGF often acts over short distances on local cells, which
ay  be an important mechanism of spatially restricting the actions
f this potent, multi-functional cytokine.
ctivation of TGF in the immune system- a key role for
ntegrins
As TGF is secreted as an inactive complex, regulation of TGF
ctivation is crucial in controlling TGF function. Early data showed
hat the latent complex of TGF could be activated by high temper-
ture, acidic pH and various proteases in vitro (Annes et al. 2003).
owever, the importance of these mechanisms in vivo remain to
e determined. Recently, a fundamental role for members of the av
ntegrin family in activating TGFb has been identiﬁed.
Integrins are a family of transmembrane receptors composed of
n  and  subunit, with 24 different integrins expressed in mam-
als (Humphries et al. 2004). Integrins are important adhesion and
ignalling receptors, mediating both cell–cell and cell-extracellular
atrix adhesion and conveying bi-directional signals across the
lasma membrane (Hynes 2002). Several integrins are also capable
f binding to a classical tri-amino acid binding motif, Arg-Gly-Asp
RGD) present in the LAP region of TGF1 and TGF3. In vitro bind-
ng studies have suggested that members of the integrin v family
v1, v3, v5, v6, v8) and integrin 81 can interact
ith the RGD site of LAP in latent TGF1 and 3 (Worthington et al.
011a). Although there is no evidence that either v1 or 81
inding to latent TGF can result in activation, strong data now
xist suggesting a critical role for other v integrins in regulating
GF activity and function during health and disease.
Seminal work by John Munger’s group ﬁrst proposed a funda-
ental role for integrins in activating TGF1 to control immune
omeostasis. Knock-in mice were generated that expressed latent
GF1, but with a point mutation in the RGD integrin binding site to
GE. Thus, mice expressed latent TGF1 but in a form that could not
e bound to or activated by integrins (TGF1RGD→RGE mice) (Yang
t al. 2007). Despite expressing similar levels of latent TGF1 to
ontrol animals, TGF1RGD→RGE mice showed a remarkably simi-
ar phenotype to mice completely lacking TGF1 production, dying
rom multi-organ inﬂammation early in life (Yang et al. 2007). Sub-
equent work has shown that integrins v6 and v8 are the
ey activators of TGF1 in the steady state immune system, as a
ombined lack of function of these integrins recapitulates the phe-
otype seen in TGF1−/− and TGF1RGD→RGE mice (Aluwihare et al.
009). Thus, integrins v6 and v8 play a non-redundant role
n the activation of TGF1 in the immune system which is required
o prevent self-harmful immune responses.
ntegrin v8-mediated TGF activation in the immune
ystem: a crucial pathway in the regulation of immune
omeostasis
After establishing a crucial role for integrins v6 and v8
n activating TGF in vivo to maintain immune homeostasis, an
mportant question became where are these integrins expressed
nd how does activation of TGF regulate immunity to prevent
nﬂammation? Expression of integrin v6 is normally restricted
o epithelial cells (Busk et al. 1992), suggesting an important role for
pithelial cell-activated TGF in regulating immune cells to main-
ain homeostasis. Expression of integrin v8 is more wide-spread,
ith expression seen in locations such as cells of the central ner-
ous system, vascular epithelial cells and astrocytes in the brain
Milner et al. 1997; Nishimura et al. 1998; Zhu et al. 2002; Cambier
t al. 2005), mesangial cells in the kidney (Khan et al. 2011) and
broblasts and epithelial cells in the airway (Araya et al. 2006).logy 217 (2012) 1259– 1265
Interestingly, integrin v8 is expressed by cells of the immune
system, most prominently in CD4+ T-cells and in DCs (Travis et al.
2007).
To reveal potential function of integrin-mediated TGF acti-
vation by cells of the immune system, conditional KO mice were
generated by crossing mice expressing a conditional ﬂoxed 8
integrin allele (Proctor et al. 2005) with mice expressing Vav1-
Cre to delete integrin v8 in all leukocytes. As the 8 subunit
only forms an integrin heterodimer with v, this approach allowed
speciﬁc deletion of integrin v8. Such mice developed an age-
related wasting disorder associated with T-cell activation and
aberrant T-cell associated antibody production and by ∼6 months
of age developed severe colitis (Travis et al. 2007). Similar results
were observed in mice lacking all v integrins in leukocytes
(Lacy-Hulbert et al. 2007). Thus, expression of integrin v8 by
leukocytes is key to maintaining T-cell homeostasis and preventing
inﬂammation of the intestine.
Additional work determined the cell type of the immune system
that expressed functionally important integrin v8. Lack of inte-
grin v8 expression in T-cells (using CD4-Cre-mediated deletion
of a conditional 8 allele) caused no phenotype in mice (Travis et al.
2007). However, when integrin v8 was  deleted in CD11c+ cells,
which are predominantly DCs (via expression of CD11c-Cre), mice
developed an identical wasting and inﬂammatory disorder to mice
lacking the integrin on all leukocytes (Travis et al. 2007). The phe-
notype was correlated with a decreased ability of DCs to activate
TGF, and also a reduced level of Foxp3+ Tregs in the large intes-
tine (Travis et al. 2007). Similar results were obtained when all v
integrins were deleted from myeloid cells (using LysM-Cre) (Lacy-
Hulbert et al. 2007). Thus, integrin v8-mediated TGF activation
by CD11c+ DCs is a crucial pathway in the maintenance of immune
homeostasis in the intestine.
A key role for integrin ˛vˇ8-mediated TGF  ˇ activation by
specialised DCs of the intestine
The intestine is a site of high immune load, given the trillions
of microorganisms that form the microﬂora, and the diverse array
of dietary antigens. Specialised immune pathways therefore exist
in the intestine to promote tolerance in the face of the heavy anti-
genic load, with an important role for TGF (Maloy and Powrie
2011). Interestingly, a recently identiﬁed tolerogenic subset of DCs
in the intestine, marked by expression of CD103, are specialised
to induce Foxp3+ Tregs. This enhanced Treg induction is linked
to their enhanced ability to produce retinoic acid, a metabolite
of Vitamin A, and is TGF-dependent (Coombes et al. 2007; Sun
et al. 2007). However, how TGF was activated in the intestine to
drive Treg induction was not understood. We  have recently shown
that CD103+ intestinal DCs, as well as producing more retinoic
acid, are specialised to activate TGF which correlates with high
expression of integrin v8 (Worthington et al. 2011b). Indeed,
enhanced TGF activation by CD103+ gut DCs promotes Foxp3+
Treg induction even when the actions of retinoic acid are blocked,
and loss of integrin v8 expression by CD103+ intestinal DCs
ablates their enhanced ability to activate TGF and induce Foxp3+
Tregs (Worthington et al. 2011b; Païdassi et al. 2011). Thus, integrin
v8-mediated TGF activation is upregulated by specialised DC
subsets in the intestine, and this pathway is crucial in maintaining
immune homeostasis in the gut.
Interestingly, although mice lacking the TGF-activating inte-
grin v8 on immune cells develop autoimmunity, this is not as
severe as mice that lack global function of integrins v6 and v8
(Aluwihare et al. 2009). Global integrin v6−/− mice develop
only mild inﬂammation of the lung and skin (Huang et al. 1996).
Crossing these mice with mice lacking integrin v8 on leukocytes,
although speeding the onset of colitis compared to mice lacking
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Fig. 2. Integrin v8-mediated TGF activation is mediated by, and acts upon DCs to regulate pro- and anti-inﬂammatory immune responses. Latent TGF binds integrin
v8  integrin via an RGD motif in the LAP region of the latent complex, resulting in the release of active TGF which can orchestrate pro- or anti-inﬂammatory responses.
Pro-inﬂammatory immunity is stimulated when (1) Th17 cells are induced from naive CD4+ T-cells DC-mediated TGF activation via integrin v8, which can result in
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ecretion and DC recruitment to the lung. Anti-inﬂammatory immunity is stimulat
4)  directly inhibits T-cell activation.
ntegrin v8 on leukocytes, does not result in rapid multi-organ
nﬂammation observed in the total absence of integrins v6 and
v8 (Dean Sheppard and Mark Travis, unpublished data). Thus,
xpression of integrin v8 on non-leukocyte cells appears to be
mportant in the maintenance of immune homeostasis. Data does
uggest that integrin v8 can activate TGF in a number of non-
mmune cell types including airway ﬁbroblasts and epithelial cells
Mu et al. 2002; Araya et al. 2006, 2007; Kitamura et al. 2011), astro-
ytes (Cambier et al. 2005; Hirota et al. 2011), and Muller glial cells
nd neurons (Arnold et al. 2012). However, the exact non-immune
ell types required for integrin v8-mediated TGF activation to
aintain immune homeostasis remain to be determined.
ntegrin v8-mediated TGF activation by dendritic cells
n inﬂammatory disorders
In addition to playing an important role in dampening immune
esponses to maintain homeostasis, activation of TGF by DCs is
rucial in promoting inﬂammation during autoimmunity. As men-
ioned earlier, as well as having important suppressive effects on
D4+ T-cells, TGF can also promote inﬂammatory T-cell responses
y promoting differentiation of Th17 cells. It is now apparent that
ntegrin v8-mediated TGF activation by DCs is important in the
evelopment of Th17 cells. DCs that lack integrin v8 expression
ave a reduced ability to induce Th17 cells in vitro, and this defect
an be rescued by the addition of active TGF (Melton et al. 2010).
ice lacking integrin v8 expression on DCs also have reduced
umbers of Th17 cells in vivo, and are protected from symptoms
uring EAE, a model of autoimmunity known to involve Th17 cells
Melton et al. 2010). Similar results are observed in mice lacking all
v integrins on myeloid cells, and when integrin-latent TGF inter-
ctions were blocked by administration of an RGD peptide (Acharya
t al. 2010). Thus, TGF activation by DCs can drive Th17-mediated
nﬂammation during autoimmune disease.TGF activation by DCs is also important in the development
f allergic disease in the lung. Mice lacking integrin v8 on DCs
isplay reduced airway hyper-responsiveness (AHR), a hallmark of
llergic asthma, during lung antigen challenge models (Kudo et al.ntegrin v8, with TGF acting in an autocrine manner to stimulate chemokine
en TGF activated by DC-expressed integrin v8: (3) induces Foxp3+ Tregs and
2012). Reduced AHR is associated with impaired Th17 cell induc-
tion, which results in attenuated IL-17-mediated smooth muscle
contraction in the airways (Kudo et al. 2012). Interestingly, lung
inﬂammation observed during challenge was similar between con-
trol mice and mice lacking integrin v8 on DCs. Thus, Th17 cells
induced in the lung via DC-mediated TGF activation appear to
play a speciﬁc function in regulating AHR during pulmonary antigen
challenge rather than driving a broader inﬂammatory response.
In addition to driving activation of TGF via integrin v8,
it has recently been shown that DCs themselves can be inﬂu-
enced by v8-mediated TGF activation in the lung. Thus,
during airway remodelling (a hallmark of lung diseases such
as asthma and chronic obstructive pulmonary disease) airway
ﬁbroblasts upregulate integrin v8 to activate TGF (Kitamura
et al. 2011). This increased activation of TGF promotes pro-
duction of the chemokines CCL2 and CCL20 by the ﬁbroblasts,
enhancing DC migration to the lung to boost adaptive immune
responses (Kitamura et al. 2011). Given the known importance
of integrin v6 expression by lung epithelial cells in regulation
of lung pathology during various pulmonary diseases (Sheppard
2004), and recent data suggesting an important role for integrin
v5-mediated TGF activation by airway smooth muscle cells in
mediating pathology during asthma (Tatler et al. 2011), it appears
that there are multiple integrin-mediated mechanisms to regulate
TGF activity in the lung during disease. Thus, it will be interesting
to determine potential cross-talk between these related mecha-
nisms of TGF activation in the lung, and how this impacts on lung
pathology during pulmonary disease.
Conclusions
Given its crucial and multi-functional role in controlling immu-
nity, it is unsurprising that the action of TGF is carefully regulated,
not only at the level of cytokine production but also by activation of
the latent complex. Recent data highlighting a crucial role for inte-
grins in activating TGF has highlighted not only a novel function
for integrin family members in vivo, but also a key immunoregula-
tory mechanism that controls both tolerogenic and inﬂammatory
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mmune responses. The ﬁnding that DCs are especially important in
ctivating TGF via integrin v8 has uncovered a novel pathway
hat allows intricate regulation of T-cell responses during health
nd disease (Fig. 2). However, many important questions remain.
ow does integrin binding to the latent complex of TGF result
n TGF activation? Mechanisms proposed include contraction
nduced stretching of the latent complex after integrin engagement
for integrins v3, v5 and v6) and protease recruitment
nd cleavage of the complex (for integrin v8) (Worthington
t al. 2011a).  However, whether these mechanisms are important
n vivo, and whether they are conserved between different cell
ypes in different tissues of the body remains to be seen. Addi-
ionally, are there subsets of cells throughout the body that are
pecialised to activate TGF via different integrin heterodimers,
kin to the upregulation of integrin v8 seen in CD103+ DCs in
he intestine? Furthermore, how are these pathways altered dur-
ng disease? Regardless, TGF-activating integrins are becoming
otential therapeutic targets in a range of immunological disor-
ers, to either stimulate anti-inﬂammatory pathways or inhibit
ro-inﬂammatory pathways during progression of chronic disease.
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